1. Home
  2. CIVB vs AURA Comparison

CIVB vs AURA Comparison

Compare CIVB & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$22.29

Market Cap

433.8M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.16

Market Cap

396.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIVB
AURA
Founded
1884
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
433.8M
396.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CIVB
AURA
Price
$22.29
$5.16
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$25.40
$20.20
AVG Volume (30 Days)
126.4K
184.4K
Earning Date
01-29-2026
11-13-2025
Dividend Yield
3.07%
N/A
EPS Growth
33.31
N/A
EPS
2.66
N/A
Revenue
$163,095,000.00
N/A
Revenue This Year
$18.06
N/A
Revenue Next Year
$11.12
N/A
P/E Ratio
$8.31
N/A
Revenue Growth
11.28
N/A
52 Week Low
$17.47
$4.35
52 Week High
$25.59
$8.60

Technical Indicators

Market Signals
Indicator
CIVB
AURA
Relative Strength Index (RSI) 40.52 30.64
Support Level $21.80 $5.30
Resistance Level $22.60 $5.58
Average True Range (ATR) 0.57 0.36
MACD -0.24 -0.11
Stochastic Oscillator 18.49 9.71

Price Performance

Historical Comparison
CIVB
AURA

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: